Benzinga | Oct 29, 2020 06:40AM EDT

Alexion Pharmaceuticals Q3 Adj. EPS $3.24 Beats $2.58 Estimate, Sales $1.59B Beat $1.42B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $3.24 per share which beat the analyst consensus estimate of $2.58 by 25.58 percent. This is a 16.13 percent increase over earnings of $2.79 per share from the same period last year. The company reported quarterly sales of $1.59 billion which beat the analyst consensus estimate of $1.42 billion by 11.90 percent. This is a 25.81 percent increase over sales of $1.26 billion the same period last year.